REQUEST A DEMO
Total
USD $0.00
Search more companies

Advanceview S.A. (Ecuador)

Main Activities: Outpatient Care Centers
Full name: Advanceview S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Intervisión Guayaquil is an ophthalmological technology center. The company offers a wide range of ophthalmological exams and medications, with a focus on prevention, detection, and treatment of ophthalmological diseases. Intervisión Guayaquil aims to be the leading Integral Eye Health Centre in Guayaquil by 2025, prioritizing patient care and satisfaction.

Headquarters
Francisco de Orellana, Milleniun Gallery Bldg. , Floor 53
Guayaquil; Guayas;

Contact Details: Purchase the Advanceview S.A. report to view the information.

Website: http://www.intervision.com.ec

Basic Information
Total Employees:
Purchase the Advanceview S.A. report to view the information.
Outstanding Shares:
Purchase the Advanceview S.A. report to view the information.
Registered Capital:
Purchase the Advanceview S.A. report to view the information.
Incorporation Date:
June 04, 2008
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
4.87%
Purchase this report to view the information.
4.87%
Purchase this report to view the information.
4.87%
Purchase this report to view the information.
4.87%
Purchase this report to view the information.
4.87%
Subsidiaries
Ecuadorable S.A.
99%
Company Performance
Financial values in the chart are available after Advanceview S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
12.26%
Total operating revenue
12.26%
Operating profit (EBIT)
76.13%
EBITDA
112.43%
Net Profit (Loss) for the Period
75.95%
Total assets
-12.24%
Total equity
-3.14%
Operating Profit Margin (ROS)
10.48%
Net Profit Margin
10.48%
Return on Equity (ROE)
9.75%
Debt to Equity Ratio
0.01%
Quick Ratio
0.28%
Cash Ratio
0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?